Gain Therapeutics, Inc., was incorporated in Delaware on June 26, 2020. The Company is a biotechnology company that develops novel small molecule therapies for the treatment of diseases in multiple therapeutic areas, including central nervous system (" CNS ") diseases, lysosomal storage disorders (" LSD "), metabolic disorders, and other diseases that can be targeted by protein degradation, such as oncology.
